Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease

Figure 1 Distribution of serum levels of lectin-like oxidized low density lipoprotein receptor-1 in healthy controls and patients according to non-alcoholic fatty liver disease Activity Score^△. The LOX-1 levels were significantly different between controls, simple steatosis and NASH (borderline + definite) cases (4.08 ± 4.32 ng/mL, 6.1 ± 6.16 ng/mL, 8.92 ± 6.45 ng/mL, respectively, P = 0.004). LOX-1: Lectin-like oxidized low density lipoprotein receptor-1; NAS: Non-alcoholic fatty liver disease Activity Score; ^△: All healthy controls were considered to have 0 point in NAS.